Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Personalized pharmacotherapy"'
Autor:
I. V. Kukes, J. M. Salmasi, K. S. Ternovoy, A. N. Kazimirskii, T. E. Obodzinskaya, V. G. Lim, P. B. Glagovskiy, I. S. Mamedov, G. V. Poryadin, A. S. Savicheva, E. A. Kukes, M. S. Ptitsyn, A. D. Andreev
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 72-88 (2021)
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 cont
Externí odkaz:
https://doaj.org/article/1c267a9d9fb644e4bdfee5cd11664e8e
Autor:
Yu. A. Sorokina, A. V. Zanozin, O. V. Zanozina, T. A. Smirnova, O. A. Novozhilova, L. V. Lovcova
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 80-84 (2020)
Introduction. Patients with type 2 diabetes are more likely to have concomitant depression. In addition, there are some studies that have alluded to a direct relationship between overweight and diabetes and daytime drowsiness.The aim of this study wa
Externí odkaz:
https://doaj.org/article/2217db5a198c4152a6f1310364cd5fc9
Autor:
O. V. Romashchenko
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 6 (2021)
Aim. To develop a personalized approach to the trimetazidine use in patients with coronary artery disease (CAD) based on the criteria for predicting the cytoprotective activity tested in vitro.Material and methods. We examined 30 patients with class
Externí odkaz:
https://doaj.org/article/1d9ea2da4bf04963a961215e485b0ec9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A. N. Kazimirskii, J. M. Salmasi, T. E. Obodzinskaya, A. S. Savicheva, P. B. Glagovskiy, V. G. Lim, A. D. Andreev, E. A. Kukes, G. V. Poryadin, I. V. Kukes, M. S. Ptitsyn, I. S. Mamedov, K. S. Ternovoy
Publikováno v:
Медицинский совет, Vol 0, Iss 12, Pp 72-88 (2021)
SARS-CoV-2 is a novel coronavirus that has been identified as the cause of the 2019 coronavirus infection (COVID-19), which originated at Wuhan city of PRC in late 2019 and widespread worldwide. As the number of patients recovering from COVID-19 cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d4de9f4e4866fabac5393f28ad5204
https://www.med-sovet.pro/jour/article/view/6334
https://www.med-sovet.pro/jour/article/view/6334
Publikováno v:
Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 57-61 (2015)
This review examines the possibility of personalized pharmacotherapy with statins, based on the genotype of the individual patient. Identification of polymorphism of genes, responsible for the metabolism of the liver CYP3A5, CYP2C9 and transport of s
Externí odkaz:
https://doaj.org/article/55b448e7bcf34034bcf29714f243f3d8
Autor:
Masaji Tani, Shin-ya Morita, Tomohiro Terada, Naoki Yabuta, Daiki Hira, Hiroya Iida, Masatomo Sudou, Satoshi Noda, Akira Andoh, Yoshinori Wakasugi, Takehide Fujimoto
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:281-288
Purpose:We aimed to evaluate exposure-toxicity/efficacy relationship of lenvatinib by determining its target trough concentration for patients with hepatocellular carcinoma (HCC).
Methods:In this retrospective, observational study, 28 HCC patien
Methods:In this retrospective, observational study, 28 HCC patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43e985a1125c6914bd8492fb325c64a1
https://doi.org/10.1007/s00280-021-04286-2
https://doi.org/10.1007/s00280-021-04286-2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Massimiliano Berretta, Luca Rinaldi, Fabrizio Di Benedetto, Arben Lleshi, Valli De Re, Gaetano Facchini, Paolo De Paoli, Raffaele Di Francia
Publikováno v:
Frontiers in Pharmacology, Vol 7 (2016)
Background: Angiogenesis inhibitors have become an important therapeutic approach in the treatment of hepatocellular carcinoma (HCC) patients. The achievement of Sorafenib in prolonging overall survival of patients with HCC makes therapeutic inhibiti
Externí odkaz:
https://doaj.org/article/15bf78aea6ab496ca83fbda35fe9705e